Regine Choe

Diffuse optical methods based on near-infrared light illumination have a great potential for detection and therapy monitoring of disease by providing information on several unique deep tissue functional/metabolic parameters. In our laboratory, we assess and improve the capabilities of diffuse optics in breast cancer detection, diagnosis and therapy monitoring. In clinical measurements of human breasts with tumor, we focus on identifying functional parameters which can serve as early indicators of therapy efficacy. Using a preclinical animal model, we study the metabolic mechanism of varied responses to therapy seen in the clinic, and investigate new therapeutic drugs and interventions. Also, we explore new functional and metabolic parameters accessible through near-infrared fluorescent optical agents.